FRONT IMMUNOL 润色咨询

Frontiers in Immunology

出版年份:2014 年文章数:22393 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:11.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=963204, encodeId=af5296320464, content=这个杂志开始要求提供原始数据了,不然过不了质检, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=68, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Thu May 06 20:48:02 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016596, encodeId=f685101659668, content=偏重的研究方向:免疫;肿瘤<br>经验分享:我的审稿人意见,今天通过邮件发我ᥬ😂᭄1周刚回来2个,一个基本2个很小的意见,可以接收,评分接近满分。另一个,评价超差,每项只得1分,直接拒稿。这样意见相差这么大,是不是还得等其他的审稿人意见?编辑拒稿概率大吗?发了两个审稿人意见邮件给我,还没有开通交互式回答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=62, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cb90736, createdName=kimbryant, createdTime=Sat Sep 11 17:56:26 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208506, encodeId=bdbb120850675, content=11.30投稿,3.22一审回来,两个审稿人,一个endorse,评分3135,提了10个意见,另外一个active,评分1222,提了7个意见,昨天返修回去,不知道是否有希望,想听听各位的意见!谢谢!🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Mon Apr 04 10:26:05 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214993, encodeId=da9b12149939d, content=这个杂志,第五步review finalize到结论要多久啊,现在5天了,知道的老师请回复一下!谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Wed Apr 27 10:57:31 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915449, encodeId=d3b4915449ec, content=有谁碰到就是系统显示没有分配到副编辑,在Editorial Assignment阶段,但是下载的最新手稿上,显示了in review, 这到底是在审稿中,还是根本还没有找到副编辑和审稿人呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Mon Jan 11 04:41:45 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0<br>偏重的研究方向:免疫;肿瘤免疫<br>经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224217, encodeId=7183122421eb9, content=想问一下各位大佬,论文投稿当天就分配了编辑,但是到现在已经8天了,还没有送外审,一般不是一个礼拜就送审了吗?编辑这是要拒还是不拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=rfRRrztQfmhBUZzkjEuflw&s=100&t=1586048905, createdBy=42965319008, createdName=李霖龙, createdTime=Fri Jun 03 10:16:01 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215240, encodeId=e36d1215240b0, content=投稿两个星期,还在initial validation阶段,有人近期遇到同样情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231202/f5d54a76129e4a5880bb7e96cd04be64/2b678d90720348f68ac1a3082a7047cc.jpg, createdBy=1fd31636241, createdName=Trafalgar_Law, createdTime=Thu Apr 28 09:20:34 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220520, encodeId=614f1220520aa, content=今年IF能过10吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Tue May 17 19:39:58 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076864, encodeId=4a8c10e68644d, content=偏重的研究方向:免疫<br>经验分享:提交原始数据十几天了还没反应,要不要催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bcea5579459, createdName=ms3000001597552618, createdTime=Sat Dec 04 15:53:34 CST 2021, time=2021-12-04, status=1, ipAttribution=)]
    2021-05-06 H·D·E

    这个杂志开始要求提供原始数据了,不然过不了质检

    68

    展开68条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=963204, encodeId=af5296320464, content=这个杂志开始要求提供原始数据了,不然过不了质检, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=68, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Thu May 06 20:48:02 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016596, encodeId=f685101659668, content=偏重的研究方向:免疫;肿瘤<br>经验分享:我的审稿人意见,今天通过邮件发我ᥬ😂᭄1周刚回来2个,一个基本2个很小的意见,可以接收,评分接近满分。另一个,评价超差,每项只得1分,直接拒稿。这样意见相差这么大,是不是还得等其他的审稿人意见?编辑拒稿概率大吗?发了两个审稿人意见邮件给我,还没有开通交互式回答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=62, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cb90736, createdName=kimbryant, createdTime=Sat Sep 11 17:56:26 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208506, encodeId=bdbb120850675, content=11.30投稿,3.22一审回来,两个审稿人,一个endorse,评分3135,提了10个意见,另外一个active,评分1222,提了7个意见,昨天返修回去,不知道是否有希望,想听听各位的意见!谢谢!🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Mon Apr 04 10:26:05 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214993, encodeId=da9b12149939d, content=这个杂志,第五步review finalize到结论要多久啊,现在5天了,知道的老师请回复一下!谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Wed Apr 27 10:57:31 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915449, encodeId=d3b4915449ec, content=有谁碰到就是系统显示没有分配到副编辑,在Editorial Assignment阶段,但是下载的最新手稿上,显示了in review, 这到底是在审稿中,还是根本还没有找到副编辑和审稿人呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Mon Jan 11 04:41:45 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0<br>偏重的研究方向:免疫;肿瘤免疫<br>经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224217, encodeId=7183122421eb9, content=想问一下各位大佬,论文投稿当天就分配了编辑,但是到现在已经8天了,还没有送外审,一般不是一个礼拜就送审了吗?编辑这是要拒还是不拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=rfRRrztQfmhBUZzkjEuflw&s=100&t=1586048905, createdBy=42965319008, createdName=李霖龙, createdTime=Fri Jun 03 10:16:01 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215240, encodeId=e36d1215240b0, content=投稿两个星期,还在initial validation阶段,有人近期遇到同样情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231202/f5d54a76129e4a5880bb7e96cd04be64/2b678d90720348f68ac1a3082a7047cc.jpg, createdBy=1fd31636241, createdName=Trafalgar_Law, createdTime=Thu Apr 28 09:20:34 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220520, encodeId=614f1220520aa, content=今年IF能过10吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Tue May 17 19:39:58 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076864, encodeId=4a8c10e68644d, content=偏重的研究方向:免疫<br>经验分享:提交原始数据十几天了还没反应,要不要催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bcea5579459, createdName=ms3000001597552618, createdTime=Sat Dec 04 15:53:34 CST 2021, time=2021-12-04, status=1, ipAttribution=)]
    2021-09-11 kimbryant

    偏重的研究方向:免疫;肿瘤
    经验分享:我的审稿人意见,今天通过邮件发我ᥬ😂᭄1周刚回来2个,一个基本2个很小的意见,可以接收,评分接近满分。另一个,评价超差,每项只得1分,直接拒稿。这样意见相差这么大,是不是还得等其他的审稿人意见?编辑拒稿概率大吗?发了两个审稿人意见邮件给我,还没有开通交互式回答

    62

    展开62条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=963204, encodeId=af5296320464, content=这个杂志开始要求提供原始数据了,不然过不了质检, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=68, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Thu May 06 20:48:02 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016596, encodeId=f685101659668, content=偏重的研究方向:免疫;肿瘤<br>经验分享:我的审稿人意见,今天通过邮件发我ᥬ😂᭄1周刚回来2个,一个基本2个很小的意见,可以接收,评分接近满分。另一个,评价超差,每项只得1分,直接拒稿。这样意见相差这么大,是不是还得等其他的审稿人意见?编辑拒稿概率大吗?发了两个审稿人意见邮件给我,还没有开通交互式回答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=62, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cb90736, createdName=kimbryant, createdTime=Sat Sep 11 17:56:26 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208506, encodeId=bdbb120850675, content=11.30投稿,3.22一审回来,两个审稿人,一个endorse,评分3135,提了10个意见,另外一个active,评分1222,提了7个意见,昨天返修回去,不知道是否有希望,想听听各位的意见!谢谢!🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Mon Apr 04 10:26:05 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214993, encodeId=da9b12149939d, content=这个杂志,第五步review finalize到结论要多久啊,现在5天了,知道的老师请回复一下!谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Wed Apr 27 10:57:31 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915449, encodeId=d3b4915449ec, content=有谁碰到就是系统显示没有分配到副编辑,在Editorial Assignment阶段,但是下载的最新手稿上,显示了in review, 这到底是在审稿中,还是根本还没有找到副编辑和审稿人呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Mon Jan 11 04:41:45 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0<br>偏重的研究方向:免疫;肿瘤免疫<br>经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224217, encodeId=7183122421eb9, content=想问一下各位大佬,论文投稿当天就分配了编辑,但是到现在已经8天了,还没有送外审,一般不是一个礼拜就送审了吗?编辑这是要拒还是不拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=rfRRrztQfmhBUZzkjEuflw&s=100&t=1586048905, createdBy=42965319008, createdName=李霖龙, createdTime=Fri Jun 03 10:16:01 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215240, encodeId=e36d1215240b0, content=投稿两个星期,还在initial validation阶段,有人近期遇到同样情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231202/f5d54a76129e4a5880bb7e96cd04be64/2b678d90720348f68ac1a3082a7047cc.jpg, createdBy=1fd31636241, createdName=Trafalgar_Law, createdTime=Thu Apr 28 09:20:34 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220520, encodeId=614f1220520aa, content=今年IF能过10吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Tue May 17 19:39:58 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076864, encodeId=4a8c10e68644d, content=偏重的研究方向:免疫<br>经验分享:提交原始数据十几天了还没反应,要不要催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bcea5579459, createdName=ms3000001597552618, createdTime=Sat Dec 04 15:53:34 CST 2021, time=2021-12-04, status=1, ipAttribution=)]
    2022-04-04 ms1000000995331571

    11.30投稿,3.22一审回来,两个审稿人,一个endorse,评分3135,提了10个意见,另外一个active,评分1222,提了7个意见,昨天返修回去,不知道是否有希望,想听听各位的意见!谢谢!🙏

    34

    展开34条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=963204, encodeId=af5296320464, content=这个杂志开始要求提供原始数据了,不然过不了质检, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=68, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Thu May 06 20:48:02 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016596, encodeId=f685101659668, content=偏重的研究方向:免疫;肿瘤<br>经验分享:我的审稿人意见,今天通过邮件发我ᥬ😂᭄1周刚回来2个,一个基本2个很小的意见,可以接收,评分接近满分。另一个,评价超差,每项只得1分,直接拒稿。这样意见相差这么大,是不是还得等其他的审稿人意见?编辑拒稿概率大吗?发了两个审稿人意见邮件给我,还没有开通交互式回答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=62, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cb90736, createdName=kimbryant, createdTime=Sat Sep 11 17:56:26 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208506, encodeId=bdbb120850675, content=11.30投稿,3.22一审回来,两个审稿人,一个endorse,评分3135,提了10个意见,另外一个active,评分1222,提了7个意见,昨天返修回去,不知道是否有希望,想听听各位的意见!谢谢!🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Mon Apr 04 10:26:05 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214993, encodeId=da9b12149939d, content=这个杂志,第五步review finalize到结论要多久啊,现在5天了,知道的老师请回复一下!谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Wed Apr 27 10:57:31 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915449, encodeId=d3b4915449ec, content=有谁碰到就是系统显示没有分配到副编辑,在Editorial Assignment阶段,但是下载的最新手稿上,显示了in review, 这到底是在审稿中,还是根本还没有找到副编辑和审稿人呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Mon Jan 11 04:41:45 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0<br>偏重的研究方向:免疫;肿瘤免疫<br>经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224217, encodeId=7183122421eb9, content=想问一下各位大佬,论文投稿当天就分配了编辑,但是到现在已经8天了,还没有送外审,一般不是一个礼拜就送审了吗?编辑这是要拒还是不拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=rfRRrztQfmhBUZzkjEuflw&s=100&t=1586048905, createdBy=42965319008, createdName=李霖龙, createdTime=Fri Jun 03 10:16:01 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215240, encodeId=e36d1215240b0, content=投稿两个星期,还在initial validation阶段,有人近期遇到同样情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231202/f5d54a76129e4a5880bb7e96cd04be64/2b678d90720348f68ac1a3082a7047cc.jpg, createdBy=1fd31636241, createdName=Trafalgar_Law, createdTime=Thu Apr 28 09:20:34 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220520, encodeId=614f1220520aa, content=今年IF能过10吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Tue May 17 19:39:58 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076864, encodeId=4a8c10e68644d, content=偏重的研究方向:免疫<br>经验分享:提交原始数据十几天了还没反应,要不要催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bcea5579459, createdName=ms3000001597552618, createdTime=Sat Dec 04 15:53:34 CST 2021, time=2021-12-04, status=1, ipAttribution=)]
    2022-04-27 ms1000000995331571

    这个杂志,第五步review finalize到结论要多久啊,现在5天了,知道的老师请回复一下!谢谢

    26

    展开26条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=963204, encodeId=af5296320464, content=这个杂志开始要求提供原始数据了,不然过不了质检, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=68, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Thu May 06 20:48:02 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016596, encodeId=f685101659668, content=偏重的研究方向:免疫;肿瘤<br>经验分享:我的审稿人意见,今天通过邮件发我ᥬ😂᭄1周刚回来2个,一个基本2个很小的意见,可以接收,评分接近满分。另一个,评价超差,每项只得1分,直接拒稿。这样意见相差这么大,是不是还得等其他的审稿人意见?编辑拒稿概率大吗?发了两个审稿人意见邮件给我,还没有开通交互式回答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=62, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cb90736, createdName=kimbryant, createdTime=Sat Sep 11 17:56:26 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208506, encodeId=bdbb120850675, content=11.30投稿,3.22一审回来,两个审稿人,一个endorse,评分3135,提了10个意见,另外一个active,评分1222,提了7个意见,昨天返修回去,不知道是否有希望,想听听各位的意见!谢谢!🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Mon Apr 04 10:26:05 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214993, encodeId=da9b12149939d, content=这个杂志,第五步review finalize到结论要多久啊,现在5天了,知道的老师请回复一下!谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Wed Apr 27 10:57:31 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915449, encodeId=d3b4915449ec, content=有谁碰到就是系统显示没有分配到副编辑,在Editorial Assignment阶段,但是下载的最新手稿上,显示了in review, 这到底是在审稿中,还是根本还没有找到副编辑和审稿人呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Mon Jan 11 04:41:45 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0<br>偏重的研究方向:免疫;肿瘤免疫<br>经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224217, encodeId=7183122421eb9, content=想问一下各位大佬,论文投稿当天就分配了编辑,但是到现在已经8天了,还没有送外审,一般不是一个礼拜就送审了吗?编辑这是要拒还是不拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=rfRRrztQfmhBUZzkjEuflw&s=100&t=1586048905, createdBy=42965319008, createdName=李霖龙, createdTime=Fri Jun 03 10:16:01 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215240, encodeId=e36d1215240b0, content=投稿两个星期,还在initial validation阶段,有人近期遇到同样情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231202/f5d54a76129e4a5880bb7e96cd04be64/2b678d90720348f68ac1a3082a7047cc.jpg, createdBy=1fd31636241, createdName=Trafalgar_Law, createdTime=Thu Apr 28 09:20:34 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220520, encodeId=614f1220520aa, content=今年IF能过10吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Tue May 17 19:39:58 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076864, encodeId=4a8c10e68644d, content=偏重的研究方向:免疫<br>经验分享:提交原始数据十几天了还没反应,要不要催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bcea5579459, createdName=ms3000001597552618, createdTime=Sat Dec 04 15:53:34 CST 2021, time=2021-12-04, status=1, ipAttribution=)]
    2021-01-11 zhanyu

    有谁碰到就是系统显示没有分配到副编辑,在Editorial Assignment阶段,但是下载的最新手稿上,显示了in review, 这到底是在审稿中,还是根本还没有找到副编辑和审稿人呀?

    23

    展开23条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=963204, encodeId=af5296320464, content=这个杂志开始要求提供原始数据了,不然过不了质检, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=68, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Thu May 06 20:48:02 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016596, encodeId=f685101659668, content=偏重的研究方向:免疫;肿瘤<br>经验分享:我的审稿人意见,今天通过邮件发我ᥬ😂᭄1周刚回来2个,一个基本2个很小的意见,可以接收,评分接近满分。另一个,评价超差,每项只得1分,直接拒稿。这样意见相差这么大,是不是还得等其他的审稿人意见?编辑拒稿概率大吗?发了两个审稿人意见邮件给我,还没有开通交互式回答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=62, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cb90736, createdName=kimbryant, createdTime=Sat Sep 11 17:56:26 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208506, encodeId=bdbb120850675, content=11.30投稿,3.22一审回来,两个审稿人,一个endorse,评分3135,提了10个意见,另外一个active,评分1222,提了7个意见,昨天返修回去,不知道是否有希望,想听听各位的意见!谢谢!🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Mon Apr 04 10:26:05 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214993, encodeId=da9b12149939d, content=这个杂志,第五步review finalize到结论要多久啊,现在5天了,知道的老师请回复一下!谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Wed Apr 27 10:57:31 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915449, encodeId=d3b4915449ec, content=有谁碰到就是系统显示没有分配到副编辑,在Editorial Assignment阶段,但是下载的最新手稿上,显示了in review, 这到底是在审稿中,还是根本还没有找到副编辑和审稿人呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Mon Jan 11 04:41:45 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0<br>偏重的研究方向:免疫;肿瘤免疫<br>经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224217, encodeId=7183122421eb9, content=想问一下各位大佬,论文投稿当天就分配了编辑,但是到现在已经8天了,还没有送外审,一般不是一个礼拜就送审了吗?编辑这是要拒还是不拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=rfRRrztQfmhBUZzkjEuflw&s=100&t=1586048905, createdBy=42965319008, createdName=李霖龙, createdTime=Fri Jun 03 10:16:01 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215240, encodeId=e36d1215240b0, content=投稿两个星期,还在initial validation阶段,有人近期遇到同样情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231202/f5d54a76129e4a5880bb7e96cd04be64/2b678d90720348f68ac1a3082a7047cc.jpg, createdBy=1fd31636241, createdName=Trafalgar_Law, createdTime=Thu Apr 28 09:20:34 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220520, encodeId=614f1220520aa, content=今年IF能过10吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Tue May 17 19:39:58 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076864, encodeId=4a8c10e68644d, content=偏重的研究方向:免疫<br>经验分享:提交原始数据十几天了还没反应,要不要催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bcea5579459, createdName=ms3000001597552618, createdTime=Sat Dec 04 15:53:34 CST 2021, time=2021-12-04, status=1, ipAttribution=)]
    2021-11-21 科研小王子66

    审稿速度:3.0
    偏重的研究方向:免疫;肿瘤免疫
    经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?

    21

    展开21条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=963204, encodeId=af5296320464, content=这个杂志开始要求提供原始数据了,不然过不了质检, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=68, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Thu May 06 20:48:02 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016596, encodeId=f685101659668, content=偏重的研究方向:免疫;肿瘤<br>经验分享:我的审稿人意见,今天通过邮件发我ᥬ😂᭄1周刚回来2个,一个基本2个很小的意见,可以接收,评分接近满分。另一个,评价超差,每项只得1分,直接拒稿。这样意见相差这么大,是不是还得等其他的审稿人意见?编辑拒稿概率大吗?发了两个审稿人意见邮件给我,还没有开通交互式回答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=62, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cb90736, createdName=kimbryant, createdTime=Sat Sep 11 17:56:26 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208506, encodeId=bdbb120850675, content=11.30投稿,3.22一审回来,两个审稿人,一个endorse,评分3135,提了10个意见,另外一个active,评分1222,提了7个意见,昨天返修回去,不知道是否有希望,想听听各位的意见!谢谢!🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Mon Apr 04 10:26:05 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214993, encodeId=da9b12149939d, content=这个杂志,第五步review finalize到结论要多久啊,现在5天了,知道的老师请回复一下!谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Wed Apr 27 10:57:31 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915449, encodeId=d3b4915449ec, content=有谁碰到就是系统显示没有分配到副编辑,在Editorial Assignment阶段,但是下载的最新手稿上,显示了in review, 这到底是在审稿中,还是根本还没有找到副编辑和审稿人呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Mon Jan 11 04:41:45 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0<br>偏重的研究方向:免疫;肿瘤免疫<br>经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224217, encodeId=7183122421eb9, content=想问一下各位大佬,论文投稿当天就分配了编辑,但是到现在已经8天了,还没有送外审,一般不是一个礼拜就送审了吗?编辑这是要拒还是不拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=rfRRrztQfmhBUZzkjEuflw&s=100&t=1586048905, createdBy=42965319008, createdName=李霖龙, createdTime=Fri Jun 03 10:16:01 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215240, encodeId=e36d1215240b0, content=投稿两个星期,还在initial validation阶段,有人近期遇到同样情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231202/f5d54a76129e4a5880bb7e96cd04be64/2b678d90720348f68ac1a3082a7047cc.jpg, createdBy=1fd31636241, createdName=Trafalgar_Law, createdTime=Thu Apr 28 09:20:34 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220520, encodeId=614f1220520aa, content=今年IF能过10吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Tue May 17 19:39:58 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076864, encodeId=4a8c10e68644d, content=偏重的研究方向:免疫<br>经验分享:提交原始数据十几天了还没反应,要不要催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bcea5579459, createdName=ms3000001597552618, createdTime=Sat Dec 04 15:53:34 CST 2021, time=2021-12-04, status=1, ipAttribution=)]
    2022-06-03 李霖龙

    想问一下各位大佬,论文投稿当天就分配了编辑,但是到现在已经8天了,还没有送外审,一般不是一个礼拜就送审了吗?编辑这是要拒还是不拒

    21

    展开21条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=963204, encodeId=af5296320464, content=这个杂志开始要求提供原始数据了,不然过不了质检, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=68, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Thu May 06 20:48:02 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016596, encodeId=f685101659668, content=偏重的研究方向:免疫;肿瘤<br>经验分享:我的审稿人意见,今天通过邮件发我ᥬ😂᭄1周刚回来2个,一个基本2个很小的意见,可以接收,评分接近满分。另一个,评价超差,每项只得1分,直接拒稿。这样意见相差这么大,是不是还得等其他的审稿人意见?编辑拒稿概率大吗?发了两个审稿人意见邮件给我,还没有开通交互式回答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=62, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cb90736, createdName=kimbryant, createdTime=Sat Sep 11 17:56:26 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208506, encodeId=bdbb120850675, content=11.30投稿,3.22一审回来,两个审稿人,一个endorse,评分3135,提了10个意见,另外一个active,评分1222,提了7个意见,昨天返修回去,不知道是否有希望,想听听各位的意见!谢谢!🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Mon Apr 04 10:26:05 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214993, encodeId=da9b12149939d, content=这个杂志,第五步review finalize到结论要多久啊,现在5天了,知道的老师请回复一下!谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Wed Apr 27 10:57:31 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915449, encodeId=d3b4915449ec, content=有谁碰到就是系统显示没有分配到副编辑,在Editorial Assignment阶段,但是下载的最新手稿上,显示了in review, 这到底是在审稿中,还是根本还没有找到副编辑和审稿人呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Mon Jan 11 04:41:45 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0<br>偏重的研究方向:免疫;肿瘤免疫<br>经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224217, encodeId=7183122421eb9, content=想问一下各位大佬,论文投稿当天就分配了编辑,但是到现在已经8天了,还没有送外审,一般不是一个礼拜就送审了吗?编辑这是要拒还是不拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=rfRRrztQfmhBUZzkjEuflw&s=100&t=1586048905, createdBy=42965319008, createdName=李霖龙, createdTime=Fri Jun 03 10:16:01 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215240, encodeId=e36d1215240b0, content=投稿两个星期,还在initial validation阶段,有人近期遇到同样情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231202/f5d54a76129e4a5880bb7e96cd04be64/2b678d90720348f68ac1a3082a7047cc.jpg, createdBy=1fd31636241, createdName=Trafalgar_Law, createdTime=Thu Apr 28 09:20:34 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220520, encodeId=614f1220520aa, content=今年IF能过10吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Tue May 17 19:39:58 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076864, encodeId=4a8c10e68644d, content=偏重的研究方向:免疫<br>经验分享:提交原始数据十几天了还没反应,要不要催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bcea5579459, createdName=ms3000001597552618, createdTime=Sat Dec 04 15:53:34 CST 2021, time=2021-12-04, status=1, ipAttribution=)]
    2022-04-28 Trafalgar_Law

    投稿两个星期,还在initial validation阶段,有人近期遇到同样情况吗

    20

    展开20条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=963204, encodeId=af5296320464, content=这个杂志开始要求提供原始数据了,不然过不了质检, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=68, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Thu May 06 20:48:02 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016596, encodeId=f685101659668, content=偏重的研究方向:免疫;肿瘤<br>经验分享:我的审稿人意见,今天通过邮件发我ᥬ😂᭄1周刚回来2个,一个基本2个很小的意见,可以接收,评分接近满分。另一个,评价超差,每项只得1分,直接拒稿。这样意见相差这么大,是不是还得等其他的审稿人意见?编辑拒稿概率大吗?发了两个审稿人意见邮件给我,还没有开通交互式回答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=62, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cb90736, createdName=kimbryant, createdTime=Sat Sep 11 17:56:26 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208506, encodeId=bdbb120850675, content=11.30投稿,3.22一审回来,两个审稿人,一个endorse,评分3135,提了10个意见,另外一个active,评分1222,提了7个意见,昨天返修回去,不知道是否有希望,想听听各位的意见!谢谢!🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Mon Apr 04 10:26:05 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214993, encodeId=da9b12149939d, content=这个杂志,第五步review finalize到结论要多久啊,现在5天了,知道的老师请回复一下!谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Wed Apr 27 10:57:31 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915449, encodeId=d3b4915449ec, content=有谁碰到就是系统显示没有分配到副编辑,在Editorial Assignment阶段,但是下载的最新手稿上,显示了in review, 这到底是在审稿中,还是根本还没有找到副编辑和审稿人呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Mon Jan 11 04:41:45 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0<br>偏重的研究方向:免疫;肿瘤免疫<br>经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224217, encodeId=7183122421eb9, content=想问一下各位大佬,论文投稿当天就分配了编辑,但是到现在已经8天了,还没有送外审,一般不是一个礼拜就送审了吗?编辑这是要拒还是不拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=rfRRrztQfmhBUZzkjEuflw&s=100&t=1586048905, createdBy=42965319008, createdName=李霖龙, createdTime=Fri Jun 03 10:16:01 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215240, encodeId=e36d1215240b0, content=投稿两个星期,还在initial validation阶段,有人近期遇到同样情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231202/f5d54a76129e4a5880bb7e96cd04be64/2b678d90720348f68ac1a3082a7047cc.jpg, createdBy=1fd31636241, createdName=Trafalgar_Law, createdTime=Thu Apr 28 09:20:34 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220520, encodeId=614f1220520aa, content=今年IF能过10吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Tue May 17 19:39:58 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076864, encodeId=4a8c10e68644d, content=偏重的研究方向:免疫<br>经验分享:提交原始数据十几天了还没反应,要不要催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bcea5579459, createdName=ms3000001597552618, createdTime=Sat Dec 04 15:53:34 CST 2021, time=2021-12-04, status=1, ipAttribution=)]
    2022-05-17 南大

    今年IF能过10吗?

    19

    展开19条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=963204, encodeId=af5296320464, content=这个杂志开始要求提供原始数据了,不然过不了质检, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=68, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Thu May 06 20:48:02 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016596, encodeId=f685101659668, content=偏重的研究方向:免疫;肿瘤<br>经验分享:我的审稿人意见,今天通过邮件发我ᥬ😂᭄1周刚回来2个,一个基本2个很小的意见,可以接收,评分接近满分。另一个,评价超差,每项只得1分,直接拒稿。这样意见相差这么大,是不是还得等其他的审稿人意见?编辑拒稿概率大吗?发了两个审稿人意见邮件给我,还没有开通交互式回答, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=62, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35cb90736, createdName=kimbryant, createdTime=Sat Sep 11 17:56:26 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208506, encodeId=bdbb120850675, content=11.30投稿,3.22一审回来,两个审稿人,一个endorse,评分3135,提了10个意见,另外一个active,评分1222,提了7个意见,昨天返修回去,不知道是否有希望,想听听各位的意见!谢谢!🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Mon Apr 04 10:26:05 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214993, encodeId=da9b12149939d, content=这个杂志,第五步review finalize到结论要多久啊,现在5天了,知道的老师请回复一下!谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Wed Apr 27 10:57:31 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915449, encodeId=d3b4915449ec, content=有谁碰到就是系统显示没有分配到副编辑,在Editorial Assignment阶段,但是下载的最新手稿上,显示了in review, 这到底是在审稿中,还是根本还没有找到副编辑和审稿人呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Mon Jan 11 04:41:45 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072534, encodeId=9d9110e25340b, content=审稿速度:3.0<br>偏重的研究方向:免疫;肿瘤免疫<br>经验分享:Your manuscript has been submitted successfully and is currently in review. You will be contacted as soon as the editor comments or reviewers' reports are ready. 这个状态啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/03/30/78ddf1664d629925b07258cd996aff0a.jpg, createdBy=ecb62236224, createdName=科研小王子66, createdTime=Sun Nov 21 16:28:26 CST 2021, time=2021-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224217, encodeId=7183122421eb9, content=想问一下各位大佬,论文投稿当天就分配了编辑,但是到现在已经8天了,还没有送外审,一般不是一个礼拜就送审了吗?编辑这是要拒还是不拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=rfRRrztQfmhBUZzkjEuflw&s=100&t=1586048905, createdBy=42965319008, createdName=李霖龙, createdTime=Fri Jun 03 10:16:01 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215240, encodeId=e36d1215240b0, content=投稿两个星期,还在initial validation阶段,有人近期遇到同样情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231202/f5d54a76129e4a5880bb7e96cd04be64/2b678d90720348f68ac1a3082a7047cc.jpg, createdBy=1fd31636241, createdName=Trafalgar_Law, createdTime=Thu Apr 28 09:20:34 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220520, encodeId=614f1220520aa, content=今年IF能过10吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/1f01e74e0a64f82ab973c71f4ea8ff19.jpg, createdBy=81da1702580, createdName=南大, createdTime=Tue May 17 19:39:58 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076864, encodeId=4a8c10e68644d, content=偏重的研究方向:免疫<br>经验分享:提交原始数据十几天了还没反应,要不要催一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bcea5579459, createdName=ms3000001597552618, createdTime=Sat Dec 04 15:53:34 CST 2021, time=2021-12-04, status=1, ipAttribution=)]
    2021-12-04 ms3000001597552618

    偏重的研究方向:免疫
    经验分享:提交原始数据十几天了还没反应,要不要催一下

    18

    展开18条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分